Studies on the Control of Hypertension
1966; Lippincott Williams & Wilkins; Volume: 33; Issue: 6 Linguagem: Inglês
10.1161/01.cir.33.6.958
ISSN1524-4539
AutoresH. Mitchell Perry, Henry A. Schroeder, Frank J. Catanzaro, Dominic Moore-Jones, Greta H. Camel,
Tópico(s)Blood Pressure and Hypertension Studies
ResumoHomeCirculationVol. 33, No. 6Studies on the Control of Hypertension Free AccessResearch ArticlePDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessResearch ArticlePDF/EPUBStudies on the Control of Hypertension VIII. Mortality, Morbidity, and Remissions During Twelve Years of Intensive Therapy H. MITCHELL PERRYJR., HENRY A. SCHROEDER, FRANK J. CATANZARO, DOMINIC MOORE-JONES and GRETA H. CAMEL H. MITCHELL PERRYJR.H. MITCHELL PERRYJR. From the Hypertension Division, Department of Internal Medicine, Washington University School of Medicine, and Barnes, Wohl, and Cochran Veterans Administration Hospitals, St. Louis, Missouri. , HENRY A. SCHROEDERHENRY A. SCHROEDER From the Hypertension Division, Department of Internal Medicine, Washington University School of Medicine, and Barnes, Wohl, and Cochran Veterans Administration Hospitals, St. Louis, Missouri. , FRANK J. CATANZAROFRANK J. CATANZARO From the Hypertension Division, Department of Internal Medicine, Washington University School of Medicine, and Barnes, Wohl, and Cochran Veterans Administration Hospitals, St. Louis, Missouri. , DOMINIC MOORE-JONESDOMINIC MOORE-JONES From the Hypertension Division, Department of Internal Medicine, Washington University School of Medicine, and Barnes, Wohl, and Cochran Veterans Administration Hospitals, St. Louis, Missouri. and GRETA H. CAMELGRETA H. CAMEL From the Hypertension Division, Department of Internal Medicine, Washington University School of Medicine, and Barnes, Wohl, and Cochran Veterans Administration Hospitals, St. Louis, Missouri. Originally published1 Jun 1966https://doi.org/10.1161/01.CIR.33.6.958Circulation. 1966;33:958–972 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Yatsu T, Miyamoto I, Kaneko-Takanuki F, Watanabe T and Takenaka T (2011) Pharmacological and Pharmacokinetic Characteristics of YM435, a Novel Dopamine DA1-Receptor Agonist, in Anaesthetized Dogs, Journal of Pharmacy and Pharmacology, 10.1111/j.2042-7158.1997.tb06131.x, 49:9, (892-896), Online publication date: 12-Apr-2011. Charalabopoulos K, Charalabopoulos A, Papalimneou V, Kiortsis D, Dimicco P, Kostoula O and Karachalios G (2005) Consequences of the discontinuation of antihypertensive treatment in successfully treated patients, International Journal of Clinical Practice, 10.1111/j.1742-1241.2005.00523.x, 59:6, (704-708) Chiang W and Jamshahi B (1998) Asymptomatic hypertension in the ED, The American Journal of Emergency Medicine, 10.1016/S0735-6757(98)90181-4, 16:7, (701-704), Online publication date: 1-Nov-1998. Yatsu T, Takizawa K, Kasai-Nakagawa C, Uchida W, Tanaka A, Asano M, Honda K and Takenaka T (1997) Hemodynamic Characterization of YM435, a Novel Dopamine DA1 Receptor Agonist, in Anesthetized Dogs, Journal of Cardiovascular Pharmacology, 10.1097/00005344-199703000-00012, 29:3, (382-388), Online publication date: 1-Mar-1997. Sato K, Kojima M and Dohi Y (2009) Antihypertensive Treatment in Patients with A History of Accelerated Malignant Hypertension, with Special Reference to Clinical Decision-Making in Changing Treatment, Clinical and Experimental Hypertension, 10.3109/10641969409072218, 16:3, (303-315), Online publication date: 1-Jan-1994. Schmieder R and Rockstroh J (1990) When is discontinuation of antihypertensive therapy indicated?, Cardiovascular Drugs and Therapy, 10.1007/BF02026496, 4:6, (1487-1494), Online publication date: 1-Nov-1990. Olubodun J, Falase A and Cole T (1990) Drug compliance in hypertensive Nigerians with and without heart failure, International Journal of Cardiology, 10.1016/0167-5273(90)90164-Z, 27:2, (229-234), Online publication date: 1-May-1990. Elliott W, Weber R, Nelson K, Oliner C, Fumo M, Gretler D, McCray G and Murphy M (1990) Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension., Circulation, 81:3, (970-977), Online publication date: 1-Mar-1990. Ruoff G (1986) Effect of withdrawal of terazosin therapy in patients with hypertension, The American Journal of Medicine, 10.1016/0002-9343(86)90850-8, 80:5, (35-41), Online publication date: 1-May-1986. Yu S, Whitworth J and Kincaid-smith P (2009) Malignant Hypertension : Aetiology and Outcome in 83 Patients, Clinical and Experimental Hypertension. Part A: Theory and Practice, 10.3109/10641968609045483, 8:7, (1211-1230), Online publication date: 1-Jan-1986. Perry H (1985) The evolution of antihypertensive therapy, The American Journal of Cardiology, 10.1016/0002-9149(85)90548-X, 56:16, (H75-H80), Online publication date: 1-Dec-1985. Baldwin D and Neugarten J (1985) Treatment of Hypertension in Renal Disease, American Journal of Kidney Diseases, 10.1016/S0272-6386(85)80067-6, 5:4, (A57-A70), Online publication date: 1-Apr-1985. Finnerty F (1984) Step-down treatment of mild systemic hypertension, The American Journal of Cardiology, 10.1016/0002-9149(84)90084-5, 53:9, (1304-1307), Online publication date: 1-May-1984. Nissinen A, Tuomilehto J, Elo J, Alasoini A, Varvikko P and Puska P (1983) North Karelia (Finland) hypertension detection project. Five-year follow-up of hypertensive cohort., Hypertension, 5:4, (564-572), Online publication date: 1-Jul-1983.Maland L, Lutz L and Castle C (1983) Effects of withdrawing diuretic therapy on blood pressure in mild hypertension., Hypertension, 5:4, (539-544), Online publication date: 1-Jul-1983. Perry H (1983) Vasodilators and their association with remission Lifelong Management of Hypertension, 10.1007/978-94-009-6732-8_7, (90-108), . Schnaper H (1983) Paramedical personnel and adherence to antihypertensive regimens Lifelong Management of Hypertension, 10.1007/978-94-009-6732-8_16, (240-249), . Nissinen A, Enlund H, Tuomilehto J and Puska P (1982) Hypertension care in the community — A comparison between an active community programme (the North Karelia Project) and the general situation, Public Health, 10.1016/S0033-3506(82)80048-6, 96:5, (256-268), Online publication date: 1-Sep-1982. Houston M (1981) Abrupt cessation of treatment in hypertension: Consideration of clinical features, mechanisms, prevention and management of the discontinuation syndrome, American Heart Journal, 10.1016/0002-8703(81)90317-3, 102:3, (415-430), Online publication date: 1-Sep-1981. Ohlsson O, Henningsen N and Malmquist I (2009) Blood Pressure, Heart Rate and Plasma Albumin in Relatives of Hypertensive Patients, Acta Medica Scandinavica, 10.1111/j.0954-6820.1981.tb11627.x, 209:1-6, (445-450) Danielson M and Lundbäck M (2009) WITHDRAWAL OF ANTIHYPERTENSIVE DRUGS IN MILD HYPERTENSION, Acta Medica Scandinavica, 10.1111/j.0954-6820.1981.tb02632.x, 209:S646, (127-131) Mailloux L, Mossey R, Susin M and Teichberg S (2009) Does Treatment of Hypertension Prevent Renal Failure?, Clinical and Experimental Dialysis and Apheresis, 10.3109/08860228109076014, 5:1-2, (197-212), Online publication date: 1-Jan-1981. Udenfriend S, Cardinale G and Spector S (1981) Hypertension-Induced Vascular Fibrosis and its Reversal by Antihypertensive Drugs Frontiers in Hypertension Research, 10.1007/978-1-4612-5899-5_69, (404-411), . Jennings G, Esler M and Korner P (1980) EFFECT OF PROLONGED TREATMENT ON HÆMODYNAMICS OF ESSENTIAL HYPERTENSION BEFORE AND AFTER AUTONOMIC BLOCK, The Lancet, 10.1016/S0140-6736(80)90059-8, 316:8187, (166-169), Online publication date: 1-Jul-1980. Vincenti F, Amend W, Abele J, Feduska N and Salvatierra O (1980) The role of hypertension in hemodialysis-associated atherosclerosis, The American Journal of Medicine, 10.1016/0002-9343(80)90104-7, 68:3, (363-369), Online publication date: 1-Mar-1980. Moser M (2016) Hypertension: A Major Controllable Public Health Problem — Industry Can Help, Occupational Health Nursing, 10.1177/216507997702500804, 25:8, (19-26), Online publication date: 1-Aug-1977. Perry H, Camel G, Carmody S, Ahmed K and Perry E (1977) Survival in hydralazine-treated hypertensive patients with and without late toxicity, Journal of Chronic Diseases, 10.1016/0021-9681(77)90073-X, 30:8, (519-528), Online publication date: 1-Aug-1977. Oczek W (2016) Malignant Hypertension, Angiology, 10.1177/000331977702800702, 28:7, (444-453), Online publication date: 1-Jul-1977. Sanfelippo M, Swenson R and Reaven G (1977) Reduction of plasma triglycerides by diet in subjects with chronic renal failure, Kidney International, 10.1038/ki.1977.7, 11:1, (54-61), Online publication date: 1-Jan-1977. Heintz R (1977) Wann ist ein Hochdruck zu behandeln? Hoher Blutdruck, 10.1007/978-3-642-72336-0_13, (106-114), . Gross F (1977) Drugs Acting on Arteriolar Smooth Muscle (Vasodilator Drugs) Antihypertensive Agents, 10.1007/978-3-642-66309-3_8, (397-476), . Haines J, Sherrard D and Tremann J (1975) Nephrectomy for Renovascular Hypertension in Azotemic Patients, Journal of Urology, 10.1016/S0022-5347(17)67153-2, 114:6, (828-831), Online publication date: 1-Dec-1975. Davidov M, Oczek W, Gavrilovich L and Finnerty F (2016) Long Term Follow-Up of Aggressive Medical Therapy of Accelerated Hypertension With Azotemia, Angiology, 10.1177/000331977502600505, 26:5, (396-407), Online publication date: 1-May-1975. Hedstrand H and Åberg H (2009) A 3-year Follow-up of Middle-aged Men with Borderline Blood Pressure, Acta Medica Scandinavica, 10.1111/j.0954-6820.1975.tb19562.x, 198:1-6, (389-395) de B. White C, Royds R and Turner P (1974) Some clinical pharmacological studies with indoramin, with observations on its therapeutic usefulness, Postgraduate Medical Journal, 10.1136/pgmj.50.590.729, 50:590, (729-733), Online publication date: 1-Dec-1974. Woods J, Blythe W and Huffines W (1974) Management of Malignant Hypertension Complicated by Renal Insufficiency, New England Journal of Medicine, 10.1056/NEJM197407042910103, 291:1, (10-14), Online publication date: 4-Jul-1974. Moser M (1974) Diazoxide — an effective vasodilator in accelerated hypertension, American Heart Journal, 10.1016/0002-8703(74)90428-1, 87:6, (791-795), Online publication date: 1-Jun-1974. (1974) Vascular Disease in Patients with Renal Failure, The Lancet, 10.1016/S0140-6736(74)91267-7, 303:7864, (967-968), Online publication date: 1-May-1974. Lowrie E, Lazarus J, Hampers C and Merrill J (1974) Cardiovascular Disease in Dialysis Patients, New England Journal of Medicine, 10.1056/NEJM197403282901311, 290:13, (737-738), Online publication date: 28-Mar-1974. Bergmann H (1974) Maßnahmen der anaesthesiologischen Vor- und Nachbehandlung zurVerbesserung der Kreislauffunktion bei Alterspatienten Anaesthesie im Alter, 10.1007/978-3-642-65872-3_4, (32-48), . White C and Compton Smith R (1973) YOGA AND BIO-FEEDBACK IN THE MANAGEMENT OF HYPERTENSION, The Lancet, 10.1016/S0140-6736(73)92983-8, 302:7839, (1212), Online publication date: 1-Nov-1973. Jonas S (1973) DOCTORS AND TORTURE, The Lancet, 10.1016/S0140-6736(73)92982-6, 302:7839, (1212), Online publication date: 1-Nov-1973. Hohenegger M (1973) FATE OF POTASSIUM SUPPLEMENTS DURING DIURETIC THERAPY, The Lancet, 10.1016/S0140-6736(73)92981-4, 302:7839, (1211-1212), Online publication date: 1-Nov-1973. Lew E (1973) High blood pressure, other risk factors and longevity: The insurance viewpoint, The American Journal of Medicine, 10.1016/0002-9343(73)90130-7, 55:3, (281-294), Online publication date: 1-Sep-1973. Perry H (1973) Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis, The American Journal of Medicine, 10.1016/0002-9343(73)90084-3, 54:1, (58-72), Online publication date: 1-Jan-1973. Page L and Sidd J (1972) Medical Management of Primary Hypertension, New England Journal of Medicine, 10.1056/NEJM197211092871905, 287:19, (960-967), Online publication date: 9-Nov-1972. Smirk F (1972) The prognosis of untreated and of treated hypertension and advantages of early treatment, American Heart Journal, 10.1016/0002-8703(72)90216-5, 83:6, (825-840), Online publication date: 1-Jun-1972. Pickering G (1972) Hypertension, The American Journal of Medicine, 10.1016/0002-9343(72)90049-6, 52:5, (570-583), Online publication date: 1-May-1972. Vaamonde C, David N and Palmer R (1971) Hypertensive Emergencies, Medical Clinics of North America, 10.1016/S0025-7125(16)32523-8, 55:2, (325-334), Online publication date: 1-Mar-1971. Gilmore H (1971) The Treatment of Chronic Hypertension, Medical Clinics of North America, 10.1016/S0025-7125(16)32522-6, 55:2, (317-324), Online publication date: 1-Mar-1971. Julius S and Schork M (1971) Borderline hypertension—A critical review, Journal of Chronic Diseases, 10.1016/0021-9681(71)90005-1, 23:10-11, (723-754), Online publication date: 1-Mar-1971. MROCZEK W, DAVIDOV M, GAVRILOVICH L and FINNERTY F (1969) The Value of Aggressive Therapy in the Hypertensive Patient with Azotemia, Circulation, 40:6, (893-904), Online publication date: 1-Dec-1969. Pomerantz H (1969) Hypotensive drug therapy in the management of hypertension, American Heart Journal, 10.1016/0002-8703(69)90475-X, 78:4, (433-436), Online publication date: 1-Oct-1969. Browne T and Poskanzer D (1969) Treatment of Strokes, New England Journal of Medicine, 10.1056/NEJM196909182811205, 281:12, (650-657), Online publication date: 18-Sep-1969. Heyden S and Gerber C (1969) Atherosclerotic cerebrovascular disease —Its nature and management, The American Journal of Medicine, 10.1016/0002-9343(69)90027-8, 46:5, (763-773), Online publication date: 1-May-1969. DUSTAN H, PAGE I, TARAZI R and FROHLICH E (1968) Arterial Pressure Responses to Discontinuing Antihypertensive Drugs, Circulation, 37:3, (370-379), Online publication date: 1-Mar-1968. Wollenweber J, Sheps S and Davis G (1968) Clinical course of atherosclerotic renovascular disease∗, The American Journal of Cardiology, 10.1016/0002-9149(68)90014-3, 21:1, (60-71), Online publication date: 1-Jan-1968. (1967) Azotemic Malignant Hypertension, New England Journal of Medicine, 10.1056/NEJM196708312770920, 277:9, (491-491), Online publication date: 31-Aug-1967. Woods J and Blythe W (1967) Management of Malignant Hypertension Complicated by Renal Insufficiency, New England Journal of Medicine, 10.1056/NEJM196707132770201, 277:2, (57-61), Online publication date: 13-Jul-1967. June 1, 1966Vol 33, Issue 6 Advertisement Article InformationMetrics © 1966 American Heart Association, Inc.https://doi.org/10.1161/01.CIR.33.6.958 Originally publishedJune 1, 1966 PDF download Advertisement
Referência(s)